NRX Pharmaceuticals, Inc. (NRXP) › Operating IncomeNRX Pharmaceuticals, Inc. (NRXP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$1.01M2019: -$713.2K2020: -$51.39M2021: -$115.80M2022: -$44.34M2023: -$27.84M2024: -$18.50M2025: -$16.22M-$16.22M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$16.22M+12.3%2024-$18.50M+33.5%2023-$27.84M+37.2%2022-$44.34M+61.7%2021-$115.80M-125.3%2020-$51.39M-7105.3%2019-$713.2K+29.1%2018-$1.01M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share